TipRanks
Go Ultimate55% OFF

Cognizant (COZ) AI Stock Analysis

3 Followers
DE:COZ

Cognizant

(XETRA:COZ)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
AI capabilities and adoptionBroad AI deployment across delivery and a substantial engagement base strengthen Cognizant’s ability to capture enterprise modernization demand. Its trained workforce, expanding certifications, and AI platforms can improve productivity while creating differentiated, repeatable services for clients over the next several quarters.
Negative Factors
Persistent margin compressionAlthough profitability remains solid, lower margins than in earlier periods suggest ongoing pricing, mix, or cost pressure within the services model. If this persists, revenue growth may translate less effectively into earnings and could constrain investment capacity or limit operating leverage.

Cognizant (COZ) vs. iShares MSCI Germany ETF (EWG)

-50%-40%-30%-20%-10%0%10%20%DE:COZ-7.03%EWG+5.34%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 28.53B
Dividend Yield
1.97%
Average Volume (3M)
172
Price to Earnings (P/E)
11.6
Beta (1Y)
0.71
Revenue Growth
-0.21%
EPS Growth
19.76%
Country
Germany
Employees
356,700
Sector
Technology
Sector Strength
61
Industry
Information Technology Services

Cognizant Business Overview & Revenue Model

Company Description

Cognizant Technology Solutions Corporation functions as a global professional services firm, delivering a comprehensive suite of consulting, technology, and outsourcing solutions across North America, Europe, and other international markets. Its oper...

Cognizant Earnings Call Summary

Earnings Call Date:Oct 28, 2026(Q3-2026)|% Change Since:-4.12%|Next Earnings Date:Feb 09, 2027
Earnings Call SentimentPositive

The call was broadly positive. Cognizant delivered solid revenue growth, its highest adjusted operating margin in four years, strong Financial Services momentum, improved bookings mix, rising AI adoption and robust cash generation. Management also highlighted significant investments in AI talent, platforms, partnerships and growth priorities. These strengths were partly offset by reduced full-year guidance, softer fourth-quarter expectations, discretionary spending pressure in health care and consumer-facing sectors, industry-specific challenges, and higher furlough and restructuring impacts.

Positive Updates

Q3 Revenue Growth and Margin Expansion
Third-quarter revenue grew 4.8% year-over-year in constant currency to $5.7 billion. Adjusted operating margin was 16.3%, up 30 basis points year-over-year and at its highest level in 4 years, marking the seventh consecutive quarter of year-over-year margin expansion.

Negative Updates

Macroeconomic Uncertainty Weighing on Discretionary Spending
Although macroeconomic conditions were largely stable in the third quarter, management said macro uncertainty was weighing more on discretionary spending in the fourth quarter, particularly in health care and consumer-facing sectors.

Company Guidance

For the fourth quarter, Cognizant expects revenue to grow 3.2% to 4.7% year-over-year in constant currency, including approximately 200 basis points from recently completed acquisitions; full year guidance is 4% to 4.4% growth in constant currency, with approximately 150 basis points of inorganic growth, and is expected to represent top-tier revenue growth this calendar year. Project Leap total cost is expected to be $180 million to $250 million, with in-year savings of around $200 million in 2026 and the program expected to run through the first quarter of 2027. Adjusted operating margin guidance is approximately 16.1%, representing 30 basis points of year-over-year expansion; free cash flow conversion is expected to be 90% to 100% of net income; the full year tax rate is around 25%, with the fourth quarter rate modestly above the full year rate; weighted average diluted share count is approximately 460 million; and full year EPS guidance is $5.72 to $5.79, representing 8% to 10% growth.

Cognizant Risk Analysis

Cognizant disclosed 1 risk factors in its most recent earnings report. Cognizant reported the most risks in the "Legal & Regulatory" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

0 New Risks

Cognizant Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

DE:COZ against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
ACNACN84Outperform$154.23B18.6426.77%2.59%6.47%11.19%
INFYINFY80Outperform$49.87B20.3034.59%4.52%-1.35%3.37%
WITWIT76Outperform$20.50B15.5315.94%4.04%0.38%-8.33%
FISFIS66Neutral$20.71B5.9722.57%4.41%18.26%2280.55%
Sector *61Neutral$37.18B12.37-10.20%1.83%8.50%-7.62%
FISVFISV49Neutral$27.61B-7.87-15.73%―-1.71%―

* Technology Sector Average

Performance Comparison

-40%-20%0%20%DE:COZACNFISFISVINFYWITDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:COZ and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:COZCognizant Technology Solutions57.20-5.92-9.37%
ACNAccenture Plc254.5615.076.29%
FISFidelity National Information Services38.99-23.38-37.48%
FISVFiserv, Inc.58.40-5.60-8.75%
INFYInfosys11.93-3.88-24.57%
WITWipro Limited2.15-0.40-15.52%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.